Dr. Michelle Balow Crosby, MD, PhD

Dr. Crosby practices at UCSD Center for Surgery of Encinitas in Encinitas, California.

Dr. Crosby's NPI, 1558549303, was assigned on February 4, 2008. Dr. Crosby graduated from Medical University of South Carolina (MUSC) in 2005. Dr. Crosby holds California license A108687.

Dr. Crosby's primary practice is UCSD Center for Surgery of Encinitas, at 477 N El Camino Real, Encinitas, CA 92024 in San Diego County. The practice phone is (661) 472-7434.

Dr. Crosby's primary practice is UCSD Center for Surgery of Encinitas in Encinitas, California. The medical group on file is Coastal Skin and Eye Institute. Dmand AI also links Dr. Crosby to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Crosby practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Crosby's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Crosby is board certified in ophthalmology by the American Board of Ophthalmology. Dmand AI has Dr. Crosby's licenses on file in 2 states: California and Georgia.

Dmand AI lists cataract, cataract surgery with lens implant, dry eye, eyelid inflammation, glaucoma, glaucoma surgery, hereditary corneal conditions and hypertensive retinopathy among the conditions Dr. Crosby treats.

CMS data shows 4,156 Medicare services from Dr. Crosby across 18 procedure codes in 2024, for 1,028 Medicare patients. Medicare paid $291,525 for them.

CMS counts 1,028 Medicare patients who saw Dr. Crosby in 2024. The largest group is 75 to 84, with 499 patients. 75% of them have high cholesterol, and 60% have high blood pressure. 1% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Crosby's median patient age at 74, with 53% women.

In 2024, Dr. Crosby wrote 919 Medicare Part D claims for 239 patients. 61% of them were for generic drugs. CMS names the drug for 774 of them, across 17 drugs with 11 or more claims each, at $105,737 in total drug cost. In 2023, CMS named 525 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Crosby for performance year 2024, reported individually. Dr. Crosby accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 278 procedures of cataract surgery by Dr. Crosby, more than 88% of the clinicians it reports for that procedure.

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Crosby, published from 2005 to 2010. 2010 was the busiest year, with 2. The most frequent topics are Interferon-gamma, Lipopolysaccharides and Melanoma. Dr. Crosby's most frequent co-authors are Christopher V. Crosby, MD, PhD and Denis Jusufbegovic, MD.

CMS Open Payments shows 131 general payments to Dr. Crosby from 24 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Alcon Laboratories Inc paid the most, $1,005.

Dmand AI lists 1 award for Dr. Crosby, most recently CMS Stage 1 EHR in 2013.

Dr. Crosby graduated from Medical University of South Carolina (MUSC) in 2005.

Dr. Crosby is in network with 17 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.